Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | Stannous chloride dihydrate | HCID 61436 | — |
| Reactant | HCID 67214857 | HCID 67214857 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 16722586 | HCID 16722586 | 28% |
Reaction Steps
To a suspension of 2-(5-methyl-3-phenyl-isoxazol-4-yl)-5-(2-nitro-phenyl)-[1,3,4]oxadiazole (2.20 g, 63.2 mmol) in ethanol (100 mL) was added under a nitrogen atmosphere aqueous HCl (1 M, 7.6 mL, 76 mmol) and tin(II) chloride dihydrate (7.13 g, 31.6 mmol). The reaction mixture was then stirred for 2 h at 90° C., cooled to ambient temperature and poured onto an aqueous solution of sodium carbonate (saturated, 50 mL) and ethyl acetate (100 mL), stirred for 1 h and was filtered over Hyflo®. The Hyflo® was then washed with ethyl acetate (500 mL) and the aqueous phase extracted with ethyl acetate (100 mL). Drying over sodium sulfate, concentration and purification by chromatography (SiO2, heptane:ethyl acetate=95:5 to 50:50) afforded the title compound (564 mg, 28%) as a white solid. MS: m/e=319.1 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07541372B2 |
|---|
| Source dataset | uspto-grants-2009_06 |
|---|
| ORD ID | ord-49dba67b9ce54a0aa9d73760c1ef2de8 |
|---|
| Source note | uspto-grants-2009_06 |
|---|